Monday, 19 October 2026European Markets

MYHOTELMATCH Stock 20.69% Up Today

Loading stream...

(vianews) - the market ended the session with myhotelmatch (mhm.pa) jumping 20.69% to €0.04 on wednesday while cac 40 dropped 0.2% to €7,324.76.

myhotelmatch's last close was €0.03, 14.2% below its 52-week high of €0.03.

about myhotelmatch

myhotelmatch s.a. engages in the development and exploitation of an online hotel reservation platform based on artificial intelligence (ai). it operates as an online travel agency based on the principle of online dating. the company, through its platform, connect a traveler and hotels with online hotel services whose profiles match. the company is based in biot, france.

earnings per share

as for profitability, myhotelmatch has a trailing twelve months eps of €-0.07.

volume

today's last reported volume for myhotelmatch is 16738600 which is 594.69% above its average volume of 2409480.

volatility

myhotelmatch's last week, last month's, and last quarter's current intraday variation average was 10.10%, 2.41%, and 5.32%.

myhotelmatch's highest amplitude of average volatility was 19.06% (last week), 9.18% (last month), and 5.32% (last quarter).

more news about myhotelmatch (mhm.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com